Award
Delivery Order #SPE2DR26FDL6A
Short-Term Delivery Order for Quillivant XR Medication to AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$381.72
Ceiling
$381.72
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Mar 17, 2026
Identifier
SPE2DR26FDL6A
NAICS
424210
This contract is a delivery order awarded under a larger indefinite delivery vehicle (IDV) contract held by AmerisourceBergen Drug Corp, a major pharmaceutical sourcing and distribution company. The specific order procures Quillivant XR 25 MG/5 ML suspension, a pharmaceutical medication, reflecting targeted replenishment within the federal pharmaceutical supply chain. The delivery order represents a short-term procurement with a performance window of approximately one day, emphasizing quick fulfillment to maintain critical medication availability. It is connected to a broader strategic contract that covers pharmaceutical supply through 2036, underscoring its importance in sustaining healthcare infrastructure. Details about competitive bidding are not specified, but the parent IDV implies an established contract framework facilitating such orders. This award was recently made, taking place in Conshohocken, Pennsylvania, highlighting ongoing, reliable delivery of essential drugs to federal agencies.
Description
4571162446!QUILLIVANT XR 25 MG/5 ML SUSP 150ML